UBS Downgrades CME Group (CME) Amid Trading Headwinds

CME Group Inc. (NASDAQ:CME) is one of the best performing crypto stocks so far in 2025. On July 24, UBS downgraded CME Group stock from “Buy” to “Neutral” and maintained its price target at $305. Analyst Alex Kramm stated that the downgrade is due to “tough comps ahead.”

UBS also cited a recent slowdown in trading activity as a primary reason for the downgrade. “Geopolitical uncertainty has helped drive volumes and the stock higher over the past year, but activity has started to slow recently, down 13% year-over-year in June so far, while comps are getting tougher,” stated Kramm.

Despite acknowledging structural growth drivers like increased retail trading, UBS expressed skepticism about significant short-term gains. The bank also reduced its earnings projections, forecasting earnings per share (EPS) for Q3 2025 at 9% below consensus estimates and 2% below for the full fiscal year 2025.

CME Group Inc. (NASDAQ:CME) is a global derivatives marketplace. It offers regulated cryptocurrency futures and options contracts, including products tied to Bitcoin, Ether, Solana, and XRP. The company also provides standardized reference rates and real-time indices for over 20 cryptocurrencies through its partnership with CF Benchmarks. CME Group’s primary crypto-related services include trading, clearing, and data solutions for institutional clients seeking exposure to digital assets.

While we acknowledge the potential of CME as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Alternative Meat Stocks to Invest In According to Analysts and Top 10 AI Stocks With Huge Upside Potential.

Disclosure: None. This article is originally published at Insider Monkey.